首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Clinical significance of slow recovery of graft function in living donor kidney transplantation.
【24h】

Clinical significance of slow recovery of graft function in living donor kidney transplantation.

机译:活体供体肾移植中移植物功能缓慢恢复的临床意义。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: The clinical significance of slow recovery of graft function (SGF) in living donor kidney transplantation is unclear. We evaluated the incidence, risk factors, and clinical outcome of SGF in living donor transplantation. METHODS: Three hundred ten living donor kidney recipients were included and categorized into immediate recovery of graft function (IGF; n=239) and SGF (n=71), according to estimated glomerular filtration rate (60 mL/min/1.73 m) at posttransplant day 14. We compared the clinical parameters, protocol biopsy findings, acute rejection (AR), and 10-year graft survival between the two groups. RESULTS: The SGF group had an older recipient age, lower ratio of donor to recipient body mass index, and higher incidence of AR than IGF group, as shown by protocol biopsies. The SGF group had significantly more AR episodes than IGF group within 12 months (21.1% vs. 13.4%, P<0.05) and during follow-up period (32.4% vs. 20.1%, P<0.05). The 10-year graft survival rate did not differ between groups, but AR presence was significantly associated with a lower graft survival in the SGF group than the IGF group (64.9% vs. 78.9%, P<0.05). CONCLUSIONS: SGF in the early posttransplant period is immunologically active and should be considered as one of the risk factors for determining long-term graft survival in living donor kidney transplantation.
机译:背景:在活体供体肾移植中缓慢恢复移植物功能(SGF)的临床意义尚不清楚。我们评估了活体供体移植中SGF的发生率,危险因素和临床结局。方法:根据估计的肾小球滤过率(60 mL / min / 1.73 m),纳入了310个活体供体肾脏接受者,归类为立即恢复移植功能(IGF; n = 239)和SGF(n = 71)。移植后第14天。我们比较了两组之间的临床参数,方案活检结果,急性排斥反应(AR)和10年移植存活率。结果:SGF组的活检显示,与IGF组相比,SGF组的受体年龄大,供体与受体体重指数的比率较低,AR的发生率较高。 SGF组在12个月内(21.1%vs. 13.4%,P <0.05)和随访期间(32.4%vs. 20.1%,P <0.05)的AR发作明显高于IGF组。各组的10年移植物存活率无差异,但AR存在与SGF组移植物存活率低于IGF组显着相关(64.9%vs. 78.9%,P <0.05)。结论:移植后早期的SGF具有免疫活性,应被视为确定活体供体肾移植长期移植存活的危险因素之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号